AVIV GAZIT

Person

NOF HARIM, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Telomerase activating compounds and methods of use thereof
- Patent number 9,670,139
- Issue date Jun 6, 2017
- Ben-Gurion University of the Negev Research and Development Authority
- Aviv Gazit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tri-aryl compounds and compositions comprising the same
- Patent number 9,663,448
- Issue date May 30, 2017
- Ben-Gurion University of the Negev Research and Development Authority
- Esther Priel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Telomerase activating compounds and methods of use thereof
- Patent number 8,609,736
- Issue date Dec 17, 2013
- Ben-Gurion University of the Negev Research and Development Authority
- Aviv Gazit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tri-aryl compounds and compositions comprising the same
- Patent number 8,604,245
- Issue date Dec 10, 2013
- Ben-Gurion University of the Negev Research and Development Authority
- Esther Priel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell line comprising vector encoding truncated FLK-1 receptor
- Patent number 7,964,399
- Issue date Jun 21, 2011
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and compositions for inhibiting cell proliferative disorders
- Patent number 7,217,737
- Issue date May 15, 2007
- Yissum Research and Development Company of the Hebrew University of Jerusalem
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
- Patent number RE38761
- Issue date Jul 19, 2005
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Truncated Flk-1 receptor protein, methods of use and a recombinant...
- Patent number 6,872,699
- Issue date Mar 29, 2005
- Max-Planck-Gesellschaft zur Foerderung der Wissenschaften, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PDGF receptor kinase inhibitory compounds, their preparation, purif...
- Patent number 6,673,798
- Issue date Jan 6, 2004
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting cell proliferative disorders
- Patent number 6,596,878
- Issue date Jul 22, 2003
- Yissum Research & Development Company of the Hebrew University
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising tyrphostins
- Patent number 6,426,366
- Issue date Jul 30, 2002
- Notox, Ltd.
- Abraham Novogrodsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PDGF receptor kinase inhibitory compounds, their preparation, purif...
- Patent number 6,358,954
- Issue date Mar 19, 2002
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of platelet derived growth factor related disorders such...
- Patent number 6,331,555
- Issue date Dec 18, 2001
- University of California
- Klaus P. Hirth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Epidermal growth factor receptor binding compounds for positron emi...
- Patent number 6,126,917
- Issue date Oct 3, 2000
- Hadasit Medical Research Services and Development Ltd.
- Eyal Mishani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of platelet derived growth factor related disorders such...
- Patent number 5,990,141
- Issue date Nov 23, 1999
- Sugen Inc.
- Klaus Peter Hirth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted phenylacrylonitrile compounds and compositions thereof...
- Patent number 5,981,569
- Issue date Nov 9, 1999
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Harald App
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PDGF receptor kinase inhibitory compounds their preparation and com...
- Patent number 5,932,580
- Issue date Aug 3, 1999
- Yissum Research and Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FLK-1 is a receptor for vascular endothelial growth factor
- Patent number 5,851,999
- Issue date Dec 22, 1998
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften ev.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treament of disorders related to vasculogenesis a...
- Patent number 5,849,742
- Issue date Dec 15, 1998
- Sugen Inc.
- Harald App
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazoline compounds and compositions thereof for the treatment of...
- Patent number 5,792,771
- Issue date Aug 11, 1998
- Sugen, Inc.
- Harald App
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting cell proliferative disorders
- Patent number 5,789,427
- Issue date Aug 4, 1998
- Sugen, Inc.
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting cell proliferative disorders
- Patent number 5,773,476
- Issue date Jun 30, 1998
- Sugen, Inc.
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of disorders related to vasculogenesis...
- Patent number 5,763,441
- Issue date Jun 9, 1998
- Sugen, Inc.
- Harald App
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of disorders related to vasculogenesis...
- Patent number 5,712,395
- Issue date Jan 27, 1998
- Yissum Research Development Corp.
- Harald App
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of platelet derived growth factor related disorders such...
- Patent number 5,700,822
- Issue date Dec 23, 1997
- The Regents of the University of California
- Klaus Peter Hirth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of platelet derived growth factor related disorders such...
- Patent number 5,700,823
- Issue date Dec 23, 1997
- Sugen, Inc.
- Klaus Peter Hirth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Styryl-substituted monocyclic and bicyclic heteroaryl compounds whi...
- Patent number 5,677,329
- Issue date Oct 14, 1997
- Rhone-Poulenc Rorer Pharmaceuticals, Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Styryl-substituted heteroaryl compounds which inhibit EGF receptor...
- Patent number 5,656,655
- Issue date Aug 12, 1997
- Rhone-Poulenc Rorer Pharmaceuticals, Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
- Patent number 5,217,999
- Issue date Jun 8, 1993
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Certain indole compounds which inhibit EGF receptor tyrosine kinase
- Patent number 5,196,446
- Issue date Mar 23, 1993
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
- Publication number 20170305836
- Publication date Oct 26, 2017
- BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Esther Priel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20140142068
- Publication date May 22, 2014
- BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Aviv Gazit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20140142067
- Publication date May 22, 2014
- BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Aviv Gazit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
- Publication number 20140107336
- Publication date Apr 17, 2014
- BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Esther Priel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20100267667
- Publication date Oct 21, 2010
- BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY
- Aviv Gazit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
- Publication number 20100256382
- Publication date Oct 7, 2010
- BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITKY
- Esther Priel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Catechol bioisosteres
- Publication number 20050143430
- Publication date Jun 30, 2005
- Aviv Gazit
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLK-1 is a receptor for vascular endothelial growth factor
- Publication number 20050107321
- Publication date May 19, 2005
- SUGEN, INC. and MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN, E.V.
- Axel Ullrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method and compositions for inhibiting cell proliferative disorders
- Publication number 20040242684
- Publication date Dec 2, 2004
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Hui Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Non-myeloablative tolerogenic treatment with tyrphostins
- Publication number 20040197335
- Publication date Oct 7, 2004
- Shimon Slavin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDGF receptor kinase inhibitory compounds, their preparation, purif...
- Publication number 20040132725
- Publication date Jul 8, 2004
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical compositions comprising tyrphostins
- Publication number 20030013748
- Publication date Jan 16, 2003
- Notox Ltd.
- Abraham Novogrodsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Flk-1 is a receptor for vascular endothelial growth factor
- Publication number 20020081650
- Publication date Jun 27, 2002
- Axel Ullrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods and compositions for inhibiting cell proliferative disorders
- Publication number 20020068687
- Publication date Jun 6, 2002
- Hui Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PDGF receptor kinase inhibitory compounds, their preparation, purif...
- Publication number 20020028817
- Publication date Mar 7, 2002
- Yissum Research Development Company of the Hebrew University of Jerusalem
- Alexander Levitzki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS TO MODULATE THE RESISTANCE OF CELLS TO APOPTOSIS MEDIATED B...
- Publication number 20010051628
- Publication date Dec 13, 2001
- H.-J. SU HUANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Telomerase activating compounds and methods of use thereof

Tri-aryl compounds and compositions comprising the same

Telomerase activating compounds and methods of use thereof

Tri-aryl compounds and compositions comprising the same

Cell line comprising vector encoding truncated FLK-1 receptor

Method and compositions for inhibiting cell proliferative disorders

Styryl compounds which inhibit EGF receptor protein tyrosine kinase

Truncated Flk-1 receptor protein, methods of use and a recombinant...

PDGF receptor kinase inhibitory compounds, their preparation, purif...

Methods and compositions for inhibiting cell proliferative disorders

Pharmaceutical compositions comprising tyrphostins

PDGF receptor kinase inhibitory compounds, their preparation, purif...

Treatment of platelet derived growth factor related disorders such...

Epidermal growth factor receptor binding compounds for positron emi...

Treatment of platelet derived growth factor related disorders such...

Substituted phenylacrylonitrile compounds and compositions thereof...

PDGF receptor kinase inhibitory compounds their preparation and com...

FLK-1 is a receptor for vascular endothelial growth factor

Compounds for the treament of disorders related to vasculogenesis a...

Quinazoline compounds and compositions thereof for the treatment of...

Methods and compositions for inhibiting cell proliferative disorders

Methods and compositions for inhibiting cell proliferative disorders

Compounds for the treatment of disorders related to vasculogenesis...

Compounds for the treatment of disorders related to vasculogenesis...

Treatment of platelet derived growth factor related disorders such...

Treatment of platelet derived growth factor related disorders such...

Styryl-substituted monocyclic and bicyclic heteroaryl compounds whi...

Styryl-substituted heteroaryl compounds which inhibit EGF receptor...

Styryl compounds which inhibit EGF receptor protein tyrosine kinase

Certain indole compounds which inhibit EGF receptor tyrosine kinase

Patents Applicationslast 30 patents

TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME

TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF

TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF

TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME

TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF

TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME

Catechol bioisosteres

FLK-1 is a receptor for vascular endothelial growth factor

Method and compositions for inhibiting cell proliferative disorders

Non-myeloablative tolerogenic treatment with tyrphostins

PDGF receptor kinase inhibitory compounds, their preparation, purif...

Pharmaceutical compositions comprising tyrphostins

Flk-1 is a receptor for vascular endothelial growth factor

Methods and compositions for inhibiting cell proliferative disorders

PDGF receptor kinase inhibitory compounds, their preparation, purif...

METHODS TO MODULATE THE RESISTANCE OF CELLS TO APOPTOSIS MEDIATED B...